Predominant role of A1 adenosine receptors in mediating adenosine induced vasodilatation of rat diaphragmatic arterioles: involvement of nitric oxide and the ATP‐dependent K+ channels
- 1 July 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 121 (7), 1355-1363
- https://doi.org/10.1038/sj.bjp.0701247
Abstract
1. We investigated, by intravital microscopy in rats, the role of the subtypes of adenosine receptors A1 (A1/AR) and A2 (A2AR) in mediating adenosine-induced vasodilatation of second and third order arterioles of the diaphragm. 2. Adenosine, and the A1AR selective agonists R(-)-N6-(2-phenylisopropyl)-adenosine (R-PIA) and N6-cyclo-pentyl-adenosine (CPA) induced a similar concentration-dependent dilatation of diaphragmatic arterioles. The non selective A2AR subtype agonist N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl) ethyl]adenosine (DPMA) also dilated diaphragmatic arterioles but induced a significantly smaller dilatation than adenosine. By contrast the selective A(2a)AR subtype agonist 2-[p-(2-carboxyethyl)phenyl amino]-5'-N-ethyl carboxamido adenosine (CGS 21680) did not modify diaphragmatic arteriolar diameter. 3. The non selective adenosine receptor antagonist 1,3-dipropyl-8-p-sulphophenylxanthine (SPX, 100 microM) and the selective A1AR antagonist 8-cyclopentyl-1,3-dipropylxanthine (CPX, 50 nM) significantly attenuated adenosine-induced dilatation of diaphragmatic arterioles. By contrast, adenosine significantly dilated diaphragmatic arterioles in the presence of A2AR antagonist 3,7-dimethyl-1-propargylxanthine (DMPX, 10 microM). 4. The dilatation induced by adenosine was unchanged by the mast cell stabilizing agent sodium cromoglycate (cromolyn, 10 microM). 5. The nitric oxide (NO) synthase inhibitor N omega-nitro-L-arginine (L-NOARG, 300 microM) attenuated the dilatation induced by adenosine, and by the A1AR and A2AR agonists. 6. The ATP-dependent K+ channel blocker glibenclamide (3 microM) significantly attenuated diaphragmatic arteriolar dilatation induced by adenosine and by the A1AR agonists R-PIA and CPA. By contrast, glibenclamide did not significantly modify arteriolar dilatation induced by the A2AR agonist DPMA. 7. These findings suggest that adenosine-induced dilatation of diaphragmatic arterioles in the rat is predominantly mediated by the A1AR, via the release of NO and activation of the ATP-dependent K+ channels.Keywords
This publication has 43 references indexed in Scilit:
- Purinergic Inhibition of Neurotransmitter Release in the Central Nervous SystemBasic & Clinical Pharmacology & Toxicology, 1995
- Importance of basal nitric oxide synthesis in regulation of myocardial blood flowCardiovascular Research, 1991
- A preparation for in vivo study of the diaphragmatic microcirculation in the ratMicrovascular Research, 1990
- Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channelsNature, 1990
- Endothelial cells metabolize NG -monomethyl-L-arginine to L-citrulline and subsequently to L-arginineBiochemical and Biophysical Research Communications, 1990
- N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptorJournal of Medicinal Chemistry, 1988
- Effects of Adenosine and its Analogues on Porcine Basilar Arteries: Are Only A2 Receptors Involved?Journal of Cerebral Blood Flow & Metabolism, 1988
- 3,7-Dimethyl-1-propargylxanthine: A potent and selective in vivo antagonist of adenosine analogsLife Sciences, 1988
- Analogs of caffeine: Antagonists with selectivity for A2 adenosine receptorsLife Sciences, 1986
- Adenosine receptors in the central nervous system: Relationship to the central actions of methylxanthinesLife Sciences, 1981